Implantable biosensor and preparation method thereof

By using flexible substrate, multi-mesh-like working electrode and biocompatible membrane in the subcutaneous implantable blood glucose monitoring sensor, the problems of insufficient accuracy and short service life are solved, and higher anti-interference ability is achieved and long-term stability simplifies the production process.

CN114224334BActive Publication Date: 2024-11-29MIRROR LIFE (SUZHOU) TECH CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202111631281.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-28
Publication Date
2024-11-29
Estimated Expiration
2041-12-28

AI Technical Summary

Technical Problem

The existing subcutaneous implantable blood glucose monitoring sensors have problems such as insufficient accuracy and short service life, especially because they are greatly affected by interfering substances, which affect the effect of blood glucose management.

Method used

Designed with flexible substrate, multiple mesh structure working electrode, reference electrode and insulating layer, combined with conductive electrocatalytic materials, glucose oxidase and biocompatible film, sensors are prepared through inkjet printing or screen printing to enhance anti-interference Capability and detection accuracy extend service life.

Benefits of technology

It improves the anti-interference ability and detection accuracy of the sensor, extends the service life, simplifies the production process, and improves the consistency and yield rate of production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114224334B_ABST
    Figure CN114224334B_ABST
Patent Text Reader

Abstract

The present invention relates to a sensor, in particular to an implantable biosensor and a preparation method. The implantable biosensor comprises: a flexible substrate; a working electrode, the working electrode being arranged on one side of the flexible substrate; a counter electrode, the counter electrode being arranged on the other side of the flexible substrate; a reference electrode, the reference electrode being arranged on the working electrode; and an insulating layer, the insulating layer being wrapped around the outer surface of the reference electrode and the counter electrode, and the insulating layer being also arranged between the reference electrode and the working electrode. The implantable biosensor provided by the present invention can enhance the anti-interference ability of the sensor, has good detection accuracy, high long-term stability, and long service life, and can also simplify the sensor production process and improve the consistency and yield rate of sensor production.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a sensor, in particular to an implantable biosensor and a preparation method thereof. Background Art

[0002] Subcutaneous implantable continuous glucose monitoring sensor is a device that is implanted in subcutaneous tissue and can continuously measure the glucose concentration and changes in the tissue fluid of a biological body. Usually, the sensor device, signal transmitter, and user terminal constitute a continuous glucose monitoring system (CGMS). When the glucose in the tissue fluid diffuses around the subcutaneous sensor, the conversion functional sensitive element in the sensor can convert the blood glucose concentration into other signals such as light intensity signals or electrical signals. The transmitter can transmit the signal to the user terminal and display the blood glucose concentration through certain algorithm processing.

[0003] Studies have shown that changes in glucose concentration in tissue fluid are strongly correlated with changes in glucose concentration in blood, especially when a person is in a calm state, the glucose concentration in tissue fluid is approximately consistent with the glucose concentration in blood. When the glucose concentration in a person's blood increases after a meal, the glucose concentration in the tissue fluid also increases accordingly; when a person is exercising vigorously, the sugar concentration in the tissue fluid decreases first, and then the glucose concentration in the blood decreases; therefore, CGMS can not only track the changing trend of blood sugar in real time, but also issue early warnings for high and low blood sugar. Through CGM data, doctors can have a more comprehensive understanding of the patient's condition, especially some critical blood sugar data in the middle of the night, so as to provide more accurate treatment; for the patient himself, because CGM eliminates the need for patients to frequently prick their fingertips to measure blood sugar, it can improve patient compliance and play a positive role in improving the patient's treatment effect.

[0004] Continuous and accurate monitoring of blood sugar levels in diabetic patients is the key to blood sugar management. Currently, products on the market still have problems with insufficient sensor accuracy and short sensor life. For example, false high blood sugar caused by taking cold medicines, the product monitoring time is only 7 days or 10 days; therefore, improving the accuracy of the sensor, reducing or eliminating the interference of some interfering substances, and extending the service life of the sensor are of positive significance to patient blood sugar management. Summary of the invention

[0005] In order to solve the above problems, the present invention provides an implantable biosensor which can enhance the anti-interference ability of the sensor, has good detection accuracy, high long-term stability and long service life.

[0006] An implantable biosensor comprises: a flexible substrate; a working electrode, which is arranged on one side of the flexible substrate; a counter electrode, which is arranged on the other side of the flexible substrate; a reference electrode, which is arranged on the working electrode; and an insulating layer, which is wrapped around the outer surfaces of the reference electrode and the counter electrode, and is also arranged between the reference electrode and the working electrode.

[0007] Preferably, the working electrode is a multi-mesh structure.

[0008] Preferably, the working electrode is made of the following raw materials in parts by mass:

[0009] Conductive material: 30-90 parts;

[0010] Conductive electrocatalytic material: 5-50 parts;

[0011] Polymer: 30-50 parts;

[0012] Glucose oxidase: 0.05-2 parts;

[0013] Cross-linking agent: 0.05-2;

[0014] Coupling agent: 0.05-2;

[0015] The conductive material is conductive carbon;

[0016] The conductive electrocatalytic material includes nano-scale platinum, and one or more of nano-iridium, carbon nanotubes, and nano-gold.

[0017] Furthermore, the conductive electrocatalytic material, conductive material, polymer, glucose oxidase, cross-linking agent, and coupling agent form a triple cross-linked network structure; the polymer in the working electrode is cross-linked into a network structure; the glucose oxidase is cross-linked with each other through the cross-linking agent to form a network structure; the glucose oxidase is also cross-linked with metal nano-platinum particles to form a network structure.

[0018] Preferably, the reference electrode is made of a mixture of silver and silver chloride, wherein the ratio of silver to silver chloride is 2-8:2-8.

[0019] Preferably, the counter electrode is made of one or more of platinum, gold, iridium or carbon materials.

[0020] Preferably, it further comprises a biocompatible film, wherein the biocompatible film is wrapped on the implantable biosensor.

[0021] Wherein, the biocompatible membrane is made of one or more of polyurethane, polycarbonate, polyethylene glycol, polyvinyl alcohol, and zwitterionic polymers; the glucose diffusion flux of the biocompatible membrane is: 1:400, 1:200, 1:100, 1:50 or 1:25.

[0022] Preferably, it further comprises a conductive layer, and the conductive layer is respectively arranged at the bottom of the working electrode and the counter electrode.

[0023] The method for preparing an implantable biosensor comprises the following steps:

[0024] preparing working electrode slurry, counter electrode slurry, reference electrode slurry, insulating slurry and biocompatible membrane solution;

[0025] Laying the working electrode slurry on one side of the flexible substrate by inkjet printing or screen printing;

[0026] Laying the counter electrode slurry on the other side of the flexible substrate by sputtering, inkjet printing or screen printing;

[0027] The insulating slurry is laid on the working electrode and the counter electrode by spraying or screen printing to form an insulating layer, and is cured by heating or light irradiation;

[0028] The reference electrode slurry is laid on the insulating layer by sputtering, inkjet printing or screen printing and is located on one side of the working electrode;

[0029] The insulating paste is laid on the reference electrode by spraying or screen printing to form an insulating layer, and is cured by heating or light exposure;

[0030] The biocompatible film solution is coated on the implantable biosensor by dip coating or spray coating to form a biocompatible film.

[0031] Preferably, when preparing the working electrode slurry, the conductive electrocatalytic material, the conductive material, the polymer, the glucose oxidase, the crosslinking agent and the coupling agent are mixed; when preparing the reference electrode slurry, the silver and the silver chloride are mixed; when preparing the insulating layer slurry, the UV-curable polymer is selected; and when preparing the biocompatible membrane solution, a 5% polyurethane solution is prepared.

[0032] Compared with the prior art, the present invention has the following beneficial effects:

[0033] The implantable biosensor provided by the present invention can enhance the anti-interference ability of the sensor, has good detection accuracy, high long-term stability and long service life; it can also simplify the sensor production process and improve the consistency and yield rate of sensor production. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 is a schematic diagram of the structure of an implantable biosensor;

[0035] Figure 2 is a schematic diagram of the triple mesh structure of the working electrode;

[0036] Figure 3 It is a schematic diagram of the structure of an implantable biosensor coated with a biocompatible membrane. DETAILED DESCRIPTION

[0037] The present invention will be further described with reference to the accompanying drawings.

[0038] This embodiment discloses a subcutaneous continuous blood glucose monitoring sensor that can eliminate or reduce the influence of interference and extend the working life. The working electrode disclosed in this embodiment mixes conductive electrocatalytic material, conductive carbon, polymer, GOX, crosslinking agent, and coupling agent into a triple mesh structure, which can reduce or eliminate the loss of GOX and greatly improve the life of the sensor; this embodiment uses platinum nanoparticles to reduce the catalytic potential of hydrogen peroxide, which can eliminate or reduce the influence of interfering substances; this embodiment forms a homogeneous phase with the electrocatalytic material and GOX, which is conducive to the diffusion of oxygen produced by electrocatalytic hydrogen peroxide to the surface of GOX, reducing the interference of the sensor with external oxygen, so that the sensor has better low oxygen performance. In addition, benefiting from the design of the working electrode layer containing protease in the sensor, instead of the traditional dipping or spraying of enzyme solution on the surface of the working electrode, it can fundamentally prevent the enzyme solution from diffusing or penetrating through the surface to the reference electrode or the counter electrode surface during the preparation process of the sensor, ensuring that no additional by-products will be generated to affect the operation of the sensor. This design is greatly beneficial to improve the long-term accuracy of the sensor.

[0039] Embodiment 1

[0040] like Figure 1 and Figure 2 As shown, the implantable biosensor includes: a flexible substrate 5, a working electrode 1, a counter electrode 2, a reference electrode 3 and an insulating layer 4. The working electrode 1 is arranged on one side of the flexible substrate 5; the counter electrode 2 is arranged on the other side of the flexible substrate 5; the reference electrode 3 is arranged on the working electrode 1; the insulating layer 4 is wrapped around the outer surface of the reference electrode 3 and the counter electrode 2, and the insulating layer 4 is also arranged between the reference electrode 3 and the working electrode 1. Among them, the counter electrode 2 is formed on the back of the working electrode 1, and it forms a circuit loop with the working electrode 1. The working electrode 1 is a multi-net structure. The reference electrode 3 is formed on the same surface as the conductive layer of the working electrode 1 and on it, and is isolated by the insulating layer 4 in the middle. The reference electrode 3 can provide a stable reference voltage to the working electrode 1.

[0041] The insulating layer 4 is respectively arranged between the working electrode 1 and the reference electrode 3 , and is also arranged outside the leads of the reference electrode 3 and the counter electrode 2 .

[0042] One end of the implantable biosensor is the detection end, and the working electrode 1, the reference electrode 3 and the counter electrode 2 are partially exposed outside the insulating layer 4. The length of the reference electrode 3 is less than the length of the working electrode 1, and the reference electrode 3 does not completely cover the working electrode 1, so that the working electrode 1 is partially exposed. The other end of the implantable biosensor is provided with an electrode lead contact for connecting the circuit drive system. The current drive system can provide a working voltage to the working electrode 1 and detect the working current flowing through the working electrode 1.

[0043] The flexible substrate 5 uses polyester film PET as the base layer, which has good flexibility and excellent biocompatibility, and has good adhesion to other materials attached thereto. The flexible substrate 5 is used as a carrier of the electrode, and its good flexibility can ensure a good experience when implanted subcutaneously, and PET is non-toxic and has good biocompatibility to ensure safety when implanted subcutaneously.

[0044] The working electrode 1 is made of the following raw materials in parts by mass:

[0045] Conductive material: 30-90 parts;

[0046] Conductive electrocatalytic material: 5-50 parts;

[0047] Polymer: 30-50 parts;

[0048] Glucose oxidase: 0.05-2 parts;

[0049] Cross-linking agent: 0.05-2;

[0050] Coupling agent: 0.05-2;

[0051] The conductive material is conductive carbon;

[0052] The conductive electrocatalytic material includes nano-scale platinum, and one or more of nano-iridium, carbon nanotubes, and nano-gold.

[0053] Conductive electrocatalytic material, conductive material, polymer, glucose oxidase, crosslinking agent, coupling agent form a triple crosslinked network structure; the polymer in the working electrode 1 is crosslinked into a network structure; glucose oxidases are crosslinked with each other through the crosslinking agent to form a network structure; glucose oxidase is also crosslinked with metal nano-platinum particles to form a network structure.

[0054] The reference electrode 3 is made of a mixture of silver and silver chloride, wherein the ratio of silver to silver chloride is 2-8:2-8.

[0055] The counter electrode 2 is made of one or more of platinum, gold, iridium or carbon materials.

[0056] The thickness of the working electrode 1 can be 1-20 um, and can also be 2 um.

[0057] The thickness of the insulating layer 4 is 10-40 um, and may also be 18-22 um.

[0058] The working electrode 1 can be adsorbed on the flexible substrate 5. When glucose molecules diffuse from the outside to the surface of the working electrode 1, the glucose oxidase in this layer can quickly catalyze the oxidation. At the same time, oxygen can oxidize the glucose oxidase GOx to produce hydrogen peroxide. The hydrogen peroxide is catalytically oxidized and decomposed into oxygen and water by the conductive electrocatalytic material therein. The generated electrons flow through the working electrode 1. The magnitude of the current shows a certain proportional relationship with the glucose concentration. The glucose concentration can be detected through this relationship.

[0059] The working electrode 1 is composed of nano-scale conductive electrocatalytic materials, conductive carbon, polymers, glucose oxidase, cross-linking agents, and coupling agents, realizing a triple cross-linked network structure, namely, the polyurethane in the working electrode 1 is cross-linked into a network structure, the glucose oxidases are cross-linked with each other in the presence of a cross-linking agent to form a network structure, and the glucose oxidase and metal nano-platinum particles are cross-linked into a network structure. The cross-linking between the polyurethane, glucose oxidase, and nano-platinum particles in the working electrode 1 is conducive to building a more solid structure. The working electrode 1 constructed in this embodiment realizes a triple mesh structure through cross-linking, which is conducive to enhancing the firmness of GOX in the working electrode 1, thereby reducing or eliminating the leakage and loss of GOX during use, and further improving the life of the biosensor; in addition, because the metal nanoparticles in the working electrode 1 are platinum nanoparticles, the high electrocatalytic property of metal platinum is fully utilized, so that the working voltage of the sensor can use a lower bias voltage, which can basically eliminate the signal generated by the interfering substance, and improve the anti-interference ability of the sensor; finally, because the electrocatalytic material and GOX form a homogeneous phase, it is conducive to the diffusion of the product oxygen generated by electrocatalytic hydrogen peroxide to the surface of GOX, reducing the interference effect of the sensor on external oxygen, so that the sensor has a better low oxygen performance. The working electrode 1 in this embodiment can also selectively fix the enzyme only on WE, and ensure that there is no enzyme on other electrodes such as RE, CE or additional auxiliary functional electrodes, thereby avoiding the generation of unexpected H2O2, thereby reducing the impact of H2O2 on the sensor and the human body.

[0060] The waterborne polyurethane is mixed evenly with glucose oxidase, nano-sized platinum particles, conductive carbon, cross-linking agent silane, and glutaraldehyde in a certain proportion, and then applied to the surface of the working electrode 1 through a certain process to form a film with uniform thickness; it has the following advantages:

[0061] First, the working electrode 1 contains nano-scale platinum particles. Due to its nanostructure, it has a stronger electrocatalytic ability for hydrogen peroxide than metal platinum. Therefore, the sensor can select a lower bias voltage, thereby basically eliminating the interference caused by some reducing interfering substances such as acetaminophen;

[0062] Secondly, the cross-linkable polymer can form a network structure after the enzyme layer is solidified. At the same time, the glucose oxidase and the cross-linking agent glutaraldehyde in the enzyme layer can also be cross-linked to form a network structure. Furthermore, the glucose oxidase can also be fixed on the surface of the platinum particles through silane and glutaraldehyde cross-linking. This multiple network structure is conducive to further reducing the loss of the enzyme, thereby further improving the life of the sensor;

[0063] Third, because the 1 nanometer platinum particle of the working electrode is integrated with the glucose oxidase to achieve the same phase, the oxygen produced by the electrocatalytic hydrogen peroxide can diffuse to the surface of the enzyme more quickly. Compared with the traditional "two interfaces", the design of the two interfaces of the electrocatalytic layer and the enzyme layer has a shorter diffusion distance, thereby providing sufficient oxygen for the oxidase to catalyze glucose and improving the performance of the sensor in a low-oxygen environment.

[0064] Embodiment 2

[0065] Based on the above embodiment 1, Figure 3 As shown, the implantable biosensor further includes a biocompatible membrane 6, which is wrapped around the implantable biosensor. The biocompatible membrane 6 is made of one or more of polyurethane, polycarbonate, polyethylene glycol, polyvinyl alcohol, and zwitterionic polymers; the glucose diffusion flux of the biocompatible membrane 6 is 1:400, 1:200, 1:100, 1:50, or 1:25.

[0066] The biocompatible membrane 6 wraps the three electrodes, forming a thin film with uniform thickness on the outer surface, with a length of about 5-8 mm. On the one hand, the membrane can provide a diffusion restriction effect, that is, it can adjust the flux of glucose diffusing from the outside to the GOX surface on the working electrode 1, such as 1:400, 1:200, 1:100, 1:50, 1:25, which can be 1:100 or 1:50. On the other hand, the biocompatible membrane 6 has excellent biocompatibility, which can ensure that the sensor can work for a long time in the human body.

[0067] Embodiment 3

[0068] On the basis of the above-mentioned embodiment 1 or embodiment 2, a conductive layer is further included, and the conductive layer is respectively arranged at the bottom of the working electrode and the counter electrode for connecting with the lead wire.

[0069] The conductive layer can be made of a material with good conductivity, such as one or both of conductive carbon and conductive graphite. The conductive layer can reduce the electrode impedance and improve the stability of the sensor operation.

[0070] Embodiment 4

[0071] The method for preparing an implantable biosensor comprises the following steps:

[0072] S1, preparing working electrode slurry, counter electrode slurry, reference electrode slurry, insulating slurry and biocompatible membrane solution; when preparing working electrode slurry, conductive electrocatalytic material, conductive material, polymer, glucose oxidase, crosslinking agent and coupling agent are mixed; when preparing reference electrode slurry, silver and silver chloride are mixed; when preparing insulating layer 4 slurry, ultraviolet curing polymer is selected; when preparing biocompatible membrane solution, 5% polyurethane solution is prepared;

[0073] S2, laying the working electrode slurry on one side of the flexible substrate 5 by inkjet printing or screen printing;

[0074] S3, laying the counter electrode slurry on the other side of the flexible substrate 5 by sputtering, inkjet printing or screen printing;

[0075] S4, laying the insulating slurry on the working electrode 1 and the counter electrode 2 by spraying or screen printing to form an insulating layer 4, and curing it by ultraviolet light;

[0076] S5, laying the reference electrode slurry on the insulating layer 4 by sputtering, inkjet printing or screen printing, and located on one side of the working electrode 1;

[0077] S6, laying the insulating slurry on the reference electrode 3 by spraying or screen printing to form an insulating layer 4, and curing it by ultraviolet light;

[0078] S7, coating the biocompatible membrane solution on the implantable biosensor by dip coating or spray coating to form a biocompatible membrane 6.

[0079] The working electrode 1 can be realized by screen printing process. The thickness of the working electrode 1 can be 1-20 um, and the thickness of the working electrode 1 can be 2 um.

[0080] The reference electrode 3 can be made of a certain proportion of silver and silver chloride materials, and can be realized on an insulating medium through processes such as sputtering, inkjet printing, and screen printing. Metallic silver can also be prepared on an insulating medium through the above processes, and then undergo a certain electrochemical treatment, such as anodizing, to become a silver-silver chloride mixture.

[0081] The counter electrode 2 may be made of nano-platinum.

[0082] The insulating layer 4 is formed on the electrode surface by spraying or screen printing, and then exposed to ultraviolet light for a certain period of time for curing. The thickness of the insulating layer 4 is 10-40 um, and can be 18-22 um.

[0083] The biocompatible membrane 6 can be made of some medical polymer materials with good biocompatibility, such as polyurethane, etc., and is formed on the entire surface of the three electrodes by preparing a 5% polyurethane THF solution by dipping or spraying, etc., with a length of 5-10um, or 5-6mm.

[0084] The technical principle of the present invention is described above in conjunction with specific embodiments. These descriptions are only for explaining the principle of the present invention and cannot be interpreted as limiting the protection scope of the present invention in any way. Based on the explanations herein, those skilled in the art can associate other specific implementations of the present invention without paying creative labor, and these methods will fall within the protection scope of the claims of the present invention.

Claims

1. Implantable biosensors, It is characterized in that include: Flexible substrate; A working electrode, wherein the working electrode is disposed on one side of the flexible substrate; a counter electrode, the counter electrode being arranged on the other side of the flexible substrate; A reference electrode, the reference electrode being disposed on the working electrode; and An insulating layer, the insulating layer wrapping around the outer surfaces of the reference electrode and the counter electrode, the insulating layer also being disposed between the reference electrode and the working electrode; The working electrode is made of the following raw materials in parts by mass: Conductive material: 30-90 parts; Conductive electrocatalytic material: 5-50 parts; Polymer: 30-50 parts; Glucose oxidase: 0.05-2 parts; Cross-linking agent: 0.05-2 parts; Coupling agent: 0.05-2 parts; The conductive material is conductive carbon; The conductive electrocatalytic material includes nano-sized platinum particles; The conductive electrocatalytic material, conductive material, polymer, glucose oxidase, crosslinking agent, and coupling agent form a triple crosslinked network structure; The polymer in the working electrode is cross-linked into a network structure; The glucose oxidases are cross-linked with each other through a cross-linking agent to form a network structure; The glucose oxidase is also cross-linked with the metal nano-platinum particles to form a network structure; The polymer is polyurethane.

2. The implantable biosensor according to claim 1, It is characterized in that The reference electrode is made of a mixture of silver and silver chloride, wherein the ratio of silver to silver chloride is 2-8:2-8.

3. The implantable biosensor according to claim 1, It is characterized in that The counter electrode is made of one or more of platinum, gold, iridium or carbon materials.

4. The implantable biosensor according to any one of claims 1 to 3, It is characterized in that The invention also comprises a biocompatible film, wherein the biocompatible film is wrapped on the implantable biosensor.

5. The implantable biosensor according to claim 4, It is characterized in that The biocompatible membrane is made of one or more of polyurethane, polycarbonate, polyethylene glycol, polyvinyl alcohol, and zwitterionic polymers; The glucose diffusion flux of the biocompatible membrane is 1:400, 1:200, 1:100, 1:50 or 1:

25.

6. The implantable biosensor according to any one of claims 1 to 3, It is characterized in that It also includes a conductive layer, which is respectively arranged at the bottom of the working electrode and the counter electrode.

7. The method for preparing the implantable biosensor according to claim 1, It is characterized in that The following steps are involved: preparing working electrode slurry, counter electrode slurry, reference electrode slurry, insulating slurry and biocompatible membrane solution; Laying the working electrode slurry on one side of the flexible substrate by inkjet printing or screen printing; Laying the counter electrode slurry on the other side of the flexible substrate by sputtering, inkjet printing or screen printing; The insulating slurry is laid on the working electrode and the counter electrode by spraying or screen printing to form an insulating layer, and is cured by heating or light; The reference electrode slurry is laid on the insulating layer by sputtering, inkjet printing or screen printing and is located on one side of the working electrode; The insulating paste is laid on the reference electrode by spraying or screen printing to form an insulating layer, and is cured by heating or light; The biocompatible film solution is coated on the implantable biosensor by dipping or spraying to form a biocompatible film.

8. The preparation method according to claim 7, It is characterized in that When preparing the working electrode slurry, the conductive electrocatalytic material, the conductive material, the polymer, the glucose oxidase, the cross-linking agent and the coupling agent are mixed; To prepare the reference electrode slurry, silver is mixed with silver chloride; Select UV-curable polymer when preparing the insulating layer slurry; When preparing the biocompatible membrane solution, a 5% polyurethane solution is prepared.

Citation Information

Patent Citations

  • Platinum and polyaniline compounded three-dimensional nanofiber functional structure glucose sensor with stainless steel needle as base and preparation method of sensor

    CN103983675A

  • Subcutaneous tissue involvement type glucose microsensor and preparation method thereof

    CN105411607A

  • Implantable blood sugar testing probe and screen printing-based manufacturing method thereof

    CN109406589A

  • Biosensor and preparation method thereof

    CN113567522A

  • Implantable biosensor

    CN211179623U